Designing Compound Libraries Targeting GPCRs

Conference paper
Part of the Ernst Schering Foundation Symposium Proceedings book series (SCHERING FOUND, volume 2006/2)


The design of compound libraries targeting GPCRs is of primary interest in pharmaceutical research because of their important role as signaling receptors and the herewith linked dominant place in the discovery portfolios. In the present symposium chapter, we outline GPCR compound library design strategies recently followed by our group and discuss them in a more general context.


Compound Library Library Design Sequence Theme Bivalent Ligand Privileged Structure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Drs. R. Bouhelal, M. Gerspacher, and K. Seuwen (all NIBR associates) are acknowledged for various discussions. The text of this chapter is based in major parts of our previous publications.


  1. Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39:2887–2893CrossRefPubMedGoogle Scholar
  2. Bleicher KH, Green LG, Martin RE, Rogers-Evans M (2004) Ligand identification for G-protein-coupled receptors: a lead generation perspective. Curr Opin Chem Biol 8:287–296CrossRefPubMedGoogle Scholar
  3. Crossley R (2004) The design of screening libraries targeted at G-protein coupled receptors. Curr Top Med Chem 4:581–588CrossRefPubMedGoogle Scholar
  4. Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RS (1988) Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem 31:2235–2246CrossRefPubMedGoogle Scholar
  5. Guo T, Hobbs DW (2003) Privileged structure-based combinatorial libraries targeting G protein-coupled receptors. Assay Drug Dev Technol 1:579–592CrossRefPubMedGoogle Scholar
  6. Halazy S (1999) G-protein coupled receptors bivalent ligands and drug design. Exp Opin Ther Patents 9:431–446CrossRefGoogle Scholar
  7. Hruby VJ (2002) Designing peptide receptor agonists and antagonists. Nat Rev Drug Discov 1:847–858CrossRefPubMedGoogle Scholar
  8. Jacoby E, Fauchère JL, Raimbaud E, Ollivier S, Michel A, Spedding M (1999) A three binding site hypothesis for the interaction of ligands with monoamine G-protein coupled receptors: implications for combinatorial ligand design. Quant Struct Act Relat 18:561–572CrossRefGoogle Scholar
  9. Jacoby E (2001) A novel chemogenomics knowledge-based ligand design strategy – application to G-protein coupled receptors. Quant Struct Act Relat 20:115–123CrossRefGoogle Scholar
  10. Jacoby E, Bouhelal R, Gerspacher M, Seuwen K (2006) The 7TM G-protein-coupled receptor target family. Chem Med Chem 1:760–782Google Scholar
  11. Jimonet P, Jäger R (2004) Strategies for designing GPCR-focused libraries and screening sets. Curr Opin Drug Discovery Dev 7:325–333Google Scholar
  12. Klabunde T, Hessler G (2002) Drug design strategies for targeting G-protein-coupled receptors. Chem Bio Chem 3:928–944PubMedGoogle Scholar
  13. Savchuck NP, Balakin KV, Tkachenko SE (2004) Exploring the chemogenomic knowledge space with annotated chemical libraries. Curr Opin Chem Biol 8:412–417CrossRefGoogle Scholar
  14. Schuffenhauer A, Floersheim P, Acklin P, Jacoby E (2003) Similarity metrics for ligands reflecting the similarity of the target proteins. J Chem Inf Comput Sci 43:391–405CrossRefPubMedGoogle Scholar
  15. Tyndall JDA, Pfeiffer B, Abbenante G, Fairlie DP (2005) Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. Chem Rev 105:793–826CrossRefPubMedGoogle Scholar
  16. Von Korff M, Steger M (2004) GPCR-tailored pharmacophore pattern recognition of small molecular ligands. J Chem Inf Comput Sci 44:1137–1147CrossRefPubMedGoogle Scholar
  17. Webb TR (2004) Some principles related to chemogenomics in compound library and template design for GPCRs. In: Kubinyi H, Müller G (eds) Chemogenomics in drug discovery – a medicinal chemistry perspective. Wiley, Weinheim, pp 313–324Google Scholar
  18. Wermuth CG (2004) Selective optimization of side activities: another way for drug discovery. J Med Chem 47:1303–1314CrossRefPubMedGoogle Scholar
  19. Wise A, Jupe SC, Rees S (2004) The identification of ligands at orphan G-protein coupled receptors. Annu Rev Pharmacol Toxicol 44:43–66CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Novartis Institutes for BioMedical ResearchDiscovery TehnologiesBaselSwitzerland

Personalised recommendations